InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-19.2%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Stanker James H. Officer active across 1 company, notably Processa Pharmaceuticals, Inc.. Cumulatively, 10 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €11k. History available since 21 June 2021. The latest transaction was filed on 12 October 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations10 total
1,675 sharesCommon StockSEC:0000897069-24-001613:0
1,675 sharesCommon StockSEC:0000897069-24-000923:0
15,000 shares@ US$0.3315.4% of flowCommon StockSEC:0000897069-23-001464:0
22,500 shares@ US$0.2416.7% of flowCommon StockSEC:0000897069-23-001436:0
12,500 shares@ US$0.8030.5% of flowCommon StockSEC:0001567619-23-002403:0
7,601 sharesCommon StockSEC:0001567619-22-015307:0
7,601 sharesCommon StockSEC:0001567619-21-014749
7,601 sharesCommon StockSEC:0001567619-21-014749:0
1,000 shares@ US$6.8118.7% of flowCommon StockSEC:0001567619-21-012484
Ideal exit: 18 Mar 2022 (T+270)
1,000 shares@ US$6.810.088% mcap50.0% of flowCommon StockSEC:0001567619-21-012484:0
Ideal exit: 18 Mar 2022 (T+270)
10 of 10 declarations
